CONTACT SITEMAP Legal
JAGSONPAL pharmaceuticals  
 
SITE SEARCH  
 
 
ABOUT US


Finance

Jagsonpal had 2011 sales revenues of $37 million. The firm’s track record is impeccable. Jagsonpal has shown consistent growth in sales revenue, profits and assets over the years. Please see the firm’s annual reports for details of the firm’s performance. Jagsonpal is a firm believer in generating value for all of its stakeholders including its customers, employees and shareholders. The firm has paid dividends to its shareholders every year for the past 19 years.

Jagsonpal started from humble beginnings as a non-corporate entity, founded by Mr. Jagmohan Singh Kochhar in 1964. Fourteen years later, in 1978 Jagsonpal was set up as a private limited company.

In 1986 Jagsonpal went public on the BSE with an issue of 17.76 lakh shares. In 1994 the company was listed on the NSE with the issue of zero coupon fully convertible debentures raising its capital to Rs. 3.27 crore. In 2004 Jagsonpal increased its capitalization by issuing bonus shares in the ratio of 3:1. The face value of the share was split to Rs. 5 per share. The present share capital of the company stands at Rs. 1309 lakh.

The original promoters of the company currently hold of 65.8% of the total equity. Jagsonpal has been in the family for three generations growing aggressively and striving to realize its mission – to spread health and healing in the world.

The Jagsonpal stock is actively traded at the National Stock Exchange of India Ltd (NSE) and the Bombay Stock Exchange Ltd (BSE).

The following table indicates the high and lows of the firm’s stock price from 1993:

YEAR HIGH LOW
1993 70
45
1994 304
36
1995 400
185
1996 230
117
1997 155
111
1998 120
78
1999 747
180
2000 789
477
2001 650
115
2002 181
83
2003 200
63
2004 283 97
2005* 45
30
2006* 36
16
2007* 35
13
2008* 18
6
2009* 28
8
2010* 26
11

* Post split & Bonus

 

 
Back to Top  
Back to Top
HOME PARTNER WITH US JOIN US ABOUT US INVESTOR RELATIONS PARTNER WITH US PRODUCTS INVESTOR RELATIONS NEWS ROOM Overview Our Mission Our Story Management Directors Finance Multi-national presence Marketing Growth Strategy Research & Development Operations